v3.26.3
Recapitalization (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Recapitalization [Abstract]    
Schedule of Ordinary Shares Issued Immediately Following the Consummation The following table reconciles the elements of the Business Combination to the consolidated statement of cash flows and the consolidated statement of changes in stockholders’ deficit for the year ended December 31, 2025:

 

Cash - trust and cash, net of redemptions   $ 306,895  
Less: transaction costs, paid     (293,631 )
Net proceeds from the Business Combination     13,264  
         
Less: accounts payable, accrued liabilities and other current liabilities combined     (3,013,837 )
Less: Convertible notes payable combined     (770,000 )
Less: Warrants liabilities combined     (230,000 )
Reverse recapitalization, net   $ (4,000,573 )

The number of Class A ordinary shares issued immediately following the consummation of the Business Combination were:

 

PC4 Class A common stock, outstanding prior to the Business Combination     9,057,927  
Less: Redemption of PC4 Class A common stock     (307,742 )
Class A common stock of PC4     8,750,185  
PC4 Class B common stock, outstanding prior to the Business Combination     1  
Business Combination Class A ordinary shares     8,750,186  
Issuance of shares related to preference shares conversion     12,185,000  
Issuance of shares related to working capital agreements     432,891  
BC2 Shares     11,450,000  
Class A ordinary shares immediately after the Business Combination     32,818,077  
Schedule of BC2 Shares was Determined  

The number of BC2 shares was determined as follows:

 

          BC2’s shares
after
 
    BC2 Shares     conversion
ratio
 
Class A ordinary shares issued to existing BC2 Shareholders     127,361,990       11,450,000  
      127,361,990       11,450,000